Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Research in Cardiology
Metadata
Title
Letter To The Editors
Author
Prof. Dr. med. Johannes Waltenberger
Publication date
01-11-2007
Publisher
Steinkopff-Verlag
Published in
Clinical Research in Cardiology / Issue 11/2007
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-007-0589-6

Other articles of this Issue 11/2007

Clinical Research in Cardiology 11/2007 Go to the issue

CLINICAL TRIALS UPDATE AND HOTLINES

Clinical Trial Updates and Hotline Sessions presented at the European Society of Cardiology Congress 2007

ORIGINAL PAPER

The Paclitaxel-Eluting Coroflex™ Please Stent Pilot Study (PECOPS I)

CLINICAL CORRESPONDENCE

Severe cardiomyopathy in a patient with renal cell carcinoma after treatment with the novel tyrosine kinase inhibitor sunitinib

ORIGINAL PAPER

Evolution of paced QRS and QTc intervals in children with epicardial pacing leads

ORIGINAL PAPER

Quality of life and occurrence of atrial fibrillation in long-term follow-up of common type atrial flutter ablation:

LETTER TO THE EDITORS

Letter to the Editors

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits